Levosimendan
TNX-LVO-04
Phase 2 small_molecule completed
Quick answer
Levosimendan for Hypertension Pulmonary Secondary is a Phase 2 program (small_molecule) at TENAX THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TENAX THERAPEUTICS, INC.
- Indication
- Hypertension Pulmonary Secondary
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed